These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11843295)
1. Establishment of a monosomy 7 leukemia cell line, MONO-7, with a ras gene mutation. Fujisaki H; Takai K; Akihisa S; Tokimasa S; Matsuda Y; Ohta H; Osugi Y; Kim JY; Hosoi G; Sako M; Hara J Int J Hematol; 2002 Jan; 75(1):72-7. PubMed ID: 11843295 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a Monosomy 7 Leukemia Cell Line, MONO-7, With aras Gene Mutation. Fujisaki H; Takai K; Sawada A; Tokimasa S; Matsuda Y; Ohta H; Osugi Y; Kim JY; Hosoi G; Sako M; Hara J Int J Hematol; 2002 Jan; 75(1):72-77. PubMed ID: 29349648 [TBL] [Abstract][Full Text] [Related]
3. Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice. Fujisaki H; Hara J; Takai K; Nakanishi K; Matsuda Y; Ohta H; Osugi Y; Tokimasa S; Taniike M; Hosoi G; Sako M; Okada S Exp Hematol; 1999 May; 27(5):826-33. PubMed ID: 10340398 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3. Ohyashiki K; Fujieda H; Miyauchi J; Ohyashiki JH; Tauchi T; Saito M; Nakazawa S; Abe K; Yamamoto K; Clark SC Leukemia; 1991 Apr; 5(4):322-31. PubMed ID: 2027299 [TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823 [TBL] [Abstract][Full Text] [Related]
6. Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. O'Connor R; Cesano A; Lange B; Finan J; Nowell PC; Clark SC; Raimondi SC; Rovera G; Santoli D Blood; 1991 Apr; 77(7):1534-45. PubMed ID: 1706955 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. Touw I; Donath J; Pouwels K; van Buitenen C; Schipper P; Santini V; Hagemeijer A; Löwenberg B; Delwel R Leukemia; 1991 Aug; 5(8):687-92. PubMed ID: 1715959 [TBL] [Abstract][Full Text] [Related]
8. Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene. Asou H; Suzukawa K; Kita K; Nakase K; Ueda H; Morishita K; Kamada N Jpn J Cancer Res; 1996 Mar; 87(3):269-74. PubMed ID: 8613429 [TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration. Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Matozaki S; Nakagawa T; Kawaguchi R; Aozaki R; Tsutsumi M; Murayama T; Koizumi T; Nishimura R; Isobe T; Chihara K Br J Haematol; 1995 Apr; 89(4):805-11. PubMed ID: 7772516 [TBL] [Abstract][Full Text] [Related]
11. Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice. Cesano A; O'Connor R; Nowell PC; Lange B; Clark SC; Santoli D Blood; 1993 May; 81(10):2714-22. PubMed ID: 8490180 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growth. Valtieri M; Santoli D; Caracciolo D; Kreider BL; Altmann SW; Tweardy DJ; Gemperlein I; Mavilio F; Lange B; Rovera G J Immunol; 1987 Jun; 138(11):4042-50. PubMed ID: 2953797 [TBL] [Abstract][Full Text] [Related]
18. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines. Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778 [TBL] [Abstract][Full Text] [Related]
19. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement. Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360 [TBL] [Abstract][Full Text] [Related]
20. Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells. McGlynn AP; Padua RA; Burnett AK; Darley RL Leuk Res; 2000 Jan; 24(1):47-54. PubMed ID: 10634645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]